InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
09/30/2010
09/30/2009
09/30/2008
09/30/2007
09/30/2006
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
--
--
--
--
--
--
Research & Development
--
--
--
--
--
--
Operating Expenses
0
0
0
0
0
0
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
0
0
0
0
0
0
Income Tax Expense
0
0
0
0
0
0
Net Income
0
0
0
0
0
0
Net Income Growth
--
--
--
--
--
--
Shares Outstanding (Diluted)
17.82
17.82
16.88
16.82
16.82
16.82
Shares Change (YoY)
--
6%
0%
0%
0%
0%
EPS (Diluted)
0
0
0
0
0
0
EPS Growth
--
-87%
-23%
-5%
310%
11%
Free Cash Flow
--
--
--
--
--
--
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
--
--
--
--
--
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
--
--
--
--
--
--
EBITDA
--
--
--
--
--
--
EBITDA Margin
--
--
--
--
--
--
D&A For EBITDA
--
--
--
--
--
--
EBIT
0
0
0
0
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Invitro International's key financial statements?
According to the latest financial statement (Form-10K), Invitro International has a total asset of $0, Net loss of $0
What are the key financial ratios for IVRO?
Invitro International's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Invitro International's revenue broken down by segment or geography?
Invitro International largest revenue segment is In-vitro (Non-animal) Consumer, Product, and Environmental Safety Test Method, at a revenue of 811,290 in the most earnings release.For geography, United States is the primary market for Invitro International, at a revenue of 513,220.
Is Invitro International profitable?
no, according to the latest financial statements, Invitro International has a net loss of $0
Does Invitro International have any liabilities?
no, Invitro International has liability of 0
How many outstanding shares for Invitro International?
Invitro International has a total outstanding shares of 17.82